Literature DB >> 240410

Stimulation and inhibition of pancreatic phospholipase A2 by local anesthetics as a result of their interaction with the substrate.

G Scherphof, H Westenberg.   

Abstract

1. At low concentrations the local anesthetic dibucaine stimulates hydrolysis by pancreatic phospholipase A2 of phospholipids extracted from rat liver mitochondria or microsomes, whereas at higher concentrations it inhibits. The action of this enzyme towards membrane-bound substrates is barely influenced by low, but inhibited by high concentrations of dibucaine. 2. Butacaine, which is a weaker anesthetic, stimulates hydrolysis of extracted phospholipids and inhibits that of membrane-bound substrates, both actions being concentration dependent. 3. The inhibitory potency of dibucaine is several times higher in NaCl than in sucrose solutions and strongly increases with decreasing pH. Neither one of these two effects is the result of a change in binding efficiency of the anesthetic to the substrates. 4. Extracted total membrane lipids bind considerably less anesthetic than an equivalent amount of native membrane. Liver phosphatidylethanolamine is more effective in binding of dibucaine than liver phosphatidylcholine. 5. Binding of dibucaine to the phospholipase, as studied by equilibrium dialysis is at the lower level of detectability. According to the same method dibucaine is unable to displace 45Ca2+ bound to the enzyme. 6. These results are interpreted as to support the view that local anesthetics interfere with pancreatic phospholipase activity by means of interaction with the substrate rather than with the enzyme.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 240410     DOI: 10.1016/0005-2760(75)90195-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

1.  The effects of amphiphilic cationic drugs and inorganic cations on the activity of phosphatidate phosphohydrolase.

Authors:  M Bowley; J Cooling; S L Burditt; D N Brindley
Journal:  Biochem J       Date:  1977-09-01       Impact factor: 3.857

2.  Investigative studies of the dermatitis caused by the larva of the brown-tail moth, Euproctis chrysorrhoea l. (Lepidoptera, Lymantriidae). III. Chemical analysis of skin reactive substances.

Authors:  M C de Jong; E Bleumink
Journal:  Arch Dermatol Res       Date:  1977-09-27       Impact factor: 3.017

Review 3.  Malignant hyperthermia: molecular defects in membrane permeability.

Authors:  K S Cheah; A M Cheah
Journal:  Experientia       Date:  1985-05-15

4.  Mechanism of action of bradykinin-induced release of prostaglandin E.

Authors:  H Juan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-10       Impact factor: 3.000

5.  Use of phospholipase A to compare phospholipid organization in synaptic membranes, myelin, and liposomes.

Authors:  M Butler; L G Abood
Journal:  J Membr Biol       Date:  1982       Impact factor: 1.843

6.  Lecithin-cholesterol acyltransferase: inhibition by local anesthetics in plasma from man and experimental animals in vitro.

Authors:  F P Bell; E V Hubert
Journal:  Lipids       Date:  1980-10       Impact factor: 1.880

7.  Effect of p-bromophenacyl bromide, an inhibitor of phospholipase A2, on arachidonic acid release and prostaglandin synthesis by the guinea-pig uterus in vitro.

Authors:  S Mitchell; N L Poyser; N H Wilson
Journal:  Br J Pharmacol       Date:  1977-01       Impact factor: 8.739

8.  Phospholipase A activity in the skin. Modulators of arachidonic acid release from phosphatidylcholine.

Authors:  V A Ziboh; J T Lord
Journal:  Biochem J       Date:  1979-11-15       Impact factor: 3.857

9.  Inhibition of LCAT in plasma from man and experimental animals by chlorpromazine.

Authors:  F P Bell; E V Hubert
Journal:  Lipids       Date:  1981-11       Impact factor: 1.880

10.  Vasoconstriction and bronchoconstriction induced by 2,5-di-(tert-butyl)1,4-benzohydroquinone, an endoplasmic reticular Ca2+-ATPase inhibitor, in isolated and perfused rat lung.

Authors:  L Atzori; G Bannenberg; A M Corriga; A Ryrfeldt; P Moldeus
Journal:  Agents Actions       Date:  1992-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.